Categories: Business

Metafrax PJSC Controlled by Seyfeddin Roustamov Reported the Results for the First Half of 2018

Metafrax PJSC Controlled by Seyfeddin Roustamov Reported the Results for the First Half of 2018

Amid improved financial indicators, Metafrax controlled by Seyfeddin Roustamov considers the opportunity to expand its largest investment project

Online PR News � 05-September-2018 – Metafrax PJSC reported the results for the first half of 2018. The company revenue under the RSA made up $183.6 million, of which net profit $73.9 million. These results are by 28.7% and 37.3% respectively higher than for the previous year. According to Metafrax beneficiary owner Seyfeddin Roustamov, the key growth drivers are the favorable market conditions and optimized business processes.

Roustamov Seyfeddin:
– We have learned to respond more quickly to fluctuations in both the domestic and foreign markets, and have achieved some success in optimizing our logistics that helped minimize unforeseen costs and make the export parity more predictable. In addition, the current market condition enabled us to increase our turnover due to the significant surge in output in the first half of the year.

With growing financial indicators, the company plans to expand its largest investment project – the construction of Ammonia-Carbamide-Melamine Plant at the production site in Gubakha (Perm Territory, Russia). The construction of this large-scale facility is currently underway. The company’s management plans to complete the construction in 2021, and is sure that it will strengthen Metafrax position in the European market of synthetic resins. At the same time, the company considers the possibility of expanding plant facilities, namely, to build another melamine plant. At the end of July, Metafrax signed a contract with Casale (Switzerland) for the development of a plant baseline design. Mr Roustamov notes that once the plant is built, Metafrax will be among the five largest producers of melamine in Europe. The project is estimated at $ 230 million.

Roustamov Seyfeddin:
– Under our development strategy, we strive to become one of the largest melamine producers in Europe. With the expanded investment project, Metafrax will be able to produce up to 80,000 tons of melamine per year.

For your reference:
Metafrax Group is one of the largest producers of methanol and its derivatives, having its production sites in Russia and Austria. Its sales geography covers more than 20 countries, including Great Britain, Finland, Austria, Germany, Switzerland, Japan, USA and others. Its beneficiary owner is Seyfeddin Roustamov.

Company Contact Information
Oleg Smirnov
http://metafrax.ru/en
+7 (342) 484-08-98
 
Read Full Article
Alex

Recent Posts

Getting Ready: LUX Helps Female Ex-Offenders Reintegrate Back to Society

LUX Launches ‘Getting Ready’ Campaign to Inspire Ex-offenders to Re-embrace Beauty and Re-enter Society with…

44 mins ago

PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA

SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…

1 hour ago

Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System

Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…

3 hours ago

Hong Kong Ups the Game with New Incentive Playbook

Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…

3 hours ago

DTEN’s Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea

DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…

4 hours ago

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…

5 hours ago